Voyager Therapeutics, Inc. - COM (VYGR)

Historical Portfolio Holders from Q4 2015 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
33.9 M
Holdings value Q1 2024
$316 M
Value change Q1 2024
+$80.2 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
127
Number of buys Q1 2024
87
Number of sells Q1 2024
-33
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
92915B106
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 33.9 M $316 M +$80.2 M $9.31 127
2023 Q4 25.6 M $216 M -$3.13 M $8.44 105
2023 Q3 25.9 M $200 M +$537 K $7.75 108
2023 Q2 25.6 M $293 M +$48.1 M $11.45 103
2023 Q1 22.6 M $175 M -$218 K $7.71 80
2022 Q4 22.7 M $139 M -$504 K $6.10 65
2022 Q3 22.6 M $134 M -$774 K $5.92 62
2022 Q2 22.8 M $134 M +$8.69 M $5.91 69
2022 Q1 21.2 M $162 M +$28.9 M $7.62 63
2021 Q4 17.5 M $47.4 M -$8.94 M $2.71 44
2021 Q3 21.3 M $56.1 M -$4.25 M $2.63 62
2021 Q2 21.9 M $90.6 M -$15.6 M $4.13 68
2021 Q1 25.6 M $121 M -$5.4 M $4.71 88
2020 Q4 27.1 M $194 M -$5 M $7.15 90
2020 Q3 27.7 M $296 M -$21.2 M $10.67 103
2020 Q2 29.2 M $369 M -$4.47 M $12.62 102
2020 Q1 29 M $265 M -$11.9 M $9.15 109
2019 Q4 30.4 M $423 M -$7.29 M $13.95 128
2019 Q3 30.4 M $522 M +$3.4 M $17.21 122
2019 Q2 29 M $788 M +$142 M $27.22 120
2019 Q1 27.1 M $519 M +$3.58 M $19.14 105
2018 Q4 27.8 M $261 M -$17 M $9.40 110
2018 Q3 28.9 M $547 M -$4.06 M $18.92 115
2018 Q2 29.1 M $569 M +$41.4 M $19.54 124
2018 Q1 27.1 M $509 M +$37 M $18.79 107
2017 Q4 25.2 M $418 M +$68.4 M $16.60 97
2017 Q3 11.3 M $233 M +$24.1 M $20.59 73
2017 Q2 10.9 M $98.1 M -$1.7 M $8.96 51
2017 Q1 11.1 M $146 M +$8.71 M $13.24 45
2016 Q4 11 M $140 M +$4.08 M $12.74 54
2016 Q3 10.6 M $128 M +$782 K $12.01 50
2016 Q2 10.6 M $116 M +$5.97 M $10.99 48
2016 Q1 10 M $87 M -$3.38 M $8.73 41
2015 Q4 10.4 M $225 M +$220 M $21.90 34